A phospholipid is the membrane-anchoring domain of a protein growth factor of molecular mass 34 kDa in placental trophoblasts.
- 1 March 1988
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 85 (6) , 2014-2018
- https://doi.org/10.1073/pnas.85.6.2014
Abstract
Recently we isolated a protein growth factor of 34 kDa from trophoblastic membranes of human placenta. A fraction (approximately equal to 50%) of the membrane-associated 34-kDa protein is peripherally associated--i.e., it can be released by high salt treatment. The remainder shows the characteristics of an integral membrane protein--i.e., its release requires detergent treatment. Here we report studies on the structural basis for membrane anchorage of the protein. Phospholipase C was found to release an immunoreactive 34-kDa polypeptide from intact isolated cytotrophoblasts. Studies with isolated trophoblastic membranes showed that phospholipase C specifically released the salt-resistant fraction of the 34-kDa polypeptide. The polypeptide released by phospholipase C showed the same electrophoretic mobility in NaDodSO4/PAGE as the polypeptide prior to phospholipase C treatment. The identity of the released protein with the 34-kDa growth factor has been established by both immunologic and receptor-binding assays. Other studies show that there is biosynthetic incorporation of [3H]myristate into the 34-kDa protein. The myristate label is labile to phospholipase C treatment. These results suggest that some of the 34-kDa protein is anchored to the plasma membrane via a posttranslationally added phospholipid. This mode of anchorage has been observed for some other membrane proteins and raises interesting questions regarding the role of this novel linkage in the mitogenic function of the 34-kDa polypeptide.Keywords
This publication has 20 references indexed in Scilit:
- A Glycan-Phosphatidylinositol-Specific Phospholipase D in Human SerumScience, 1987
- Purification of a phosphatidylinositol-glycan-specific phospholipase C from liver plasma membranes: a possible target of insulin action.Proceedings of the National Academy of Sciences, 1987
- Eukaryotic protein modification and membrane attachment via phosphatidylinositolCell, 1987
- Structural characterization of the TAP molecule: A phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1Cell, 1986
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activityNature, 1986
- A specific antibody to a new peptide growth factor from human placenta: immunocytochemical studies on its location and biosynthesisBiochemistry, 1986
- Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoproteinNature, 1985
- Solubilization of Membrane‐Bound Acetyicholinesterase by a Phosphatidylinositol‐Specific Phospholipase CJournal of Neurochemistry, 1985
- [85] Phosphatidylinositol-specific phospholipase C from Staphylococcus aureusPublished by Elsevier ,1981